产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 185214 | 维立韦罗马来酸盐 | 599179-03-0 | >98% |  |
| 维立韦罗,也称为SCH 417690和SCH-D, 是一种有效的、具有口服活性和选 | ||||
| 18583 | Verinurad | 1352792-74-5 | >98% |  |
| Verinurad,也称为RDEA3170，是一种有机阴离子转运体URAT1 (SLC22A12)抑制 | ||||
| 18582 | VcMMAE | 646502-53-6 | >98% |  |
| VcMMAE是一种MMAE衍生物，它与valine-citrulline (Vc)链接器。VcMMAE可用于 | ||||
| 18581 | VH298 | 2097381-85-4 | >98% |  |
| VH298是一种有效的VHL抑制剂，通过不同的机制和抒发缺氧反应稳定 | ||||
| 18576 | VU0467154 | 1451993-15-9 | ≧98.0% |  |
| VU0467154 is a positive allosteric modulator of theM4 muscarinic acetylcholine recept | ||||
| 18572 | Voxilaprevir | 1535212-07-7 | >98% |  |
| Voxilaprevir是一种丙型肝炎病毒(HCV)非结构蛋白3/4A蛋白酶抑制剂。 | ||||
| 18417 | Verubecestat TFA | 2095432-65-6 | >98% |  |
| Verubecestat，也被称为MK-8931或SCH 900931，是一种有效的选择性的-分泌 | ||||
| 1783010 | Valbenazine | 1025504-45-3 | 98.0% |  |
| Valbenazine，也叫 NBI- 98854和MT - 5199，是一种有效的选择性的VMAT2抑制 | ||||
| 178307 | 沃拉帕沙 | 705260-08-8 | 98.0% |  |
| 沃拉帕沙，也被称为SCH 530348，是一种基于天然产品himbacine的凝血 | ||||
| 178306 | Voruciclib | 1000023-04-0 | 98.0% |  |
| Voruciclib，又称P1446A-05，是一种蛋白质激酶抑制剂，专门针对细胞 | ||||
| 178916 | Voxelotor(GBT440, GTX011) | 1446321-46-5 | 98.0% | -cas-1446321-46-5.png) |
| Voxelotor(GBT440,GTX011)是一种新的小分子化合物，它能增加血红蛋白与 | ||||
| 2017886 | 维利西呱 | 1350653-20-1 | 98.0% |  |
| 维利西呱，也称为BAY1021189或BAY10-21189, 是一种有效和口服活性sGC刺 | ||||
| 2017885 | Varlitinib | 845272-21-1 | 98.0% |  |
| ARRY334543是一种有效且选择性的ErbB-1和ErbB-2抑制剂(IC50分别为7和2 n | ||||
| 2017879 | VX-984 (M9831) | 1562396-65-9 | 98.0% | -cas-1562396-65-9.png) |
| VX-984, 也称为M9831,是一种ATP-竞争性抑制剂，依赖蛋白激酶(DNA-PK)的 | ||||
| 20178219 | Volasertib | 755038-65-4 | 98.0% |  |
| Volasertib, 也称为BI-6727,是一种dihydropteridinone Polo样激酶1 (Plk1) 抑制 | ||||
| 17031001 | VPS34抑制剂1 | 1383716-46-8 | 98% | |
| VPS34抑制剂1(化合物19, PIK-III类似物)是VPS34的有效和选择性抑制剂， | ||||
| 17022808 | 维帕他韦 | 1377049-84-7 | 98% | |
| 维帕他韦(VEL, GS-5816)是一种新的泛基因型丙型肝炎病毒(HCV)非结构 | ||||
| 17022704 | 伏立诺他 | 149647-78-9 | 98% |  |
| 伏立诺他(SAHA)是IC50为10nm的HDAC1 / 3抑制剂。 | ||||
| 17011903 | 氨己烯酸 | 60643-86-9 | 98% |  |
| 氨己烯酸, 是一种抗癫痫药物,抑制γ-aminobutyric酸的分解(GABA)充当 | ||||
| 6121401 | Vadadustat ( AKB-6548 ) | 1000025-07-9 | 98% | _1000025-07-9.png) |
| Vadadustat (AKB-6548), a novel, titratable, oral hypoxia-inducible factor prolyl hydr | ||||
| 611932 | VLX1570 | 1431280-51-1 | 98% |  |
| VLX1570 is a competitive inhibitor of proteasome DUB activity with IC50 ranging from | ||||
| 160926001 | Voxtalisib ( XL-765) | 934493-76-2 | 98% by HPLC | -cas-934493-76-2.png) |
| PI3K/mTOR dual kinase inhibitor XL765 inhibits both PI3K kinase and mTOR kinase, whic | ||||
| 16070916 | Vorapaxar(free base) | 618385-01-6 | 98% by HPLC | -cas-618385-01-6.png) |
| Vorapaxar, also known as SCH 530348, is a thrombin receptor (protease-activated recep | ||||
| 16070804 | VX-702 | 745833-23-2 | 98% by HPLC |  |
| VX-702, one of a series of second-generation, is an orally active p38 MAP kinase inhi | ||||
| 011115 | Vsp34-IN-1 | 1523404-29-6 | 98% |  |
| Coming soon! | ||||
| 011112 | VP 14637 | 235106-62-4 | 98% |  |
| Coming soon! | ||||
| 010436 | Vipadenant | 442908-10-3 | 98% |  |
| Vipadenant is an adenosine A2a antagonist with Ki of 1.3 nM; less potent for A1(Ki=69 | ||||
| 010434 | Vatalanib | 212141-54-3 | 98% |  |
| Vatalanib free base is an inhibitor of VEGFR2/KDR with IC50 of 37 nM, less potent aga | ||||
| 122817 | VE-821 | 1232410-49-9 | 98% |  |
| VE-821 is a potent and selective ATP competitive inhibitor of ATR with Ki/IC50 of 13 | ||||
| 122401 | VU 0364439 | 1246086-78-1 | 98% |  |
| VU 0364439 is a mGlu4 positive allosteric modulator, with EC50 of 19.8 nM. | ||||